精神分裂症：概述与治疗选择
Schizophrenia: overview and treatment options.
作者信息
Patel Krishna R, Cherian Jessica, Gohil Kunj, Atkinson Dylan
出版信息
P T. 2014 Sep;39(9):638-45.
Abstract
Schizophrenia is a complex disorder characterized by an array of symptoms. This heterogeneity has resulted in a lack of consensus regarding diagnostic criteria, etiology, and pathophysiology, and has complicated efforts to devise effective treatments.
摘要
精神分裂症是一种具有一系列症状的复杂疾病。这种异质性导致在诊断标准、病因和病理生理学方面缺乏共识，并使设计有效治疗方法的努力变得复杂。
相似文献
1
Schizophrenia: overview and treatment options.精神分裂症：概述与治疗选择
P T. 2014 Sep;39(9):638-45.
2
Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: a clinical overview.平衡治疗安全性与疗效以改善精神分裂症的临床和经济结局：临床概述
Am J Manag Care. 2014 Jun;20(8 Suppl):S160-5.
3
An Overview on the Search for Schizophrenia Biomarkers.精神分裂症生物标志物研究综述
CNS Neurol Disord Drug Targets. 2015;14(8):996-1000. doi: 10.2174/1871527314666150909114957.
4
Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights.基因组时代的精神分裂症：从发病机制、遗传和环境病因到诊断与治疗见解的综述
Psychiatr Genet. 2020 Feb;30(1):1-9. doi: 10.1097/YPG.0000000000000245.
5
Treatment-refractory schizophrenia.难治性精神分裂症
Dialogues Clin Neurosci. 2004 Mar;6(1):61-70. doi: 10.31887/DCNS.2004.6.1/acaspi.
6
Animal models of schizophrenia.精神分裂症的动物模型。
Curr Top Behav Neurosci. 2010;4:391-433. doi: 10.1007/7854_2010_62.
7
Remission in schizophrenia: proposed criteria and rationale for consensus.精神分裂症的缓解：共识的提议标准及基本原理
Am J Psychiatry. 2005 Mar;162(3):441-9. doi: 10.1176/appi.ajp.162.3.441.
8
Treating Negative Symptoms in Schizophrenia: an Update.精神分裂症阴性症状的治疗：最新进展
Curr Treat Options Psychiatry. 2016;3:133-150. doi: 10.1007/s40501-016-0075-8. Epub 2016 Apr 8.
9
More than one century of schizophrenia: an evolving perspective.一个多世纪以来的精神分裂症：不断演变的视角。
J Nerv Ment Dis. 2012 Dec;200(12):1054-7. doi: 10.1097/NMD.0b013e318275d249.
10
Neurobiology of schizophrenia.精神分裂症的神经生物学
Ann Neurol. 2000 Oct;48(4):556-66.
引用本文的文献
1
Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences.探索精神分裂症及其药物治疗对健康相关生活质量和治疗偏好的影响。
Patient Prefer Adherence. 2025 Aug 27;19:2647-2661. doi: 10.2147/PPA.S494721. eCollection 2025.
2
Effect of Activity Therapy on Self-Esteem among Patients with Schizophrenia: A Randomized Controlled Trial.活动疗法对精神分裂症患者自尊的影响：一项随机对照试验。
J Caring Sci. 2025 Jun 7;14(2):80-85. doi: 10.34172/jcs.025.33341. eCollection 2025 Jul.
3
The Impact of Adjunctive Aripiprazole on Olanzapine-Induced Metabolic Adverse Effects in Patients With Schizophrenia: A Systematic Review.阿立哌唑辅助治疗对精神分裂症患者奥氮平所致代谢不良反应的影响：一项系统评价
Neuropsychopharmacol Rep. 2025 Sep;45(3):e70046. doi: 10.1002/npr2.70046.
4
Psychometric Properties of the Arabic Version of the Pictorial Empathy Test for Assessing Affective Empathic Reactions in Patients with Schizophrenia.用于评估精神分裂症患者情感共情反应的《图片共情测试》阿拉伯语版本的心理测量特性。
Healthcare (Basel). 2025 Aug 16;13(16):2022. doi: 10.3390/healthcare13162022.
5
The effects of dance intervention on clinical symptoms and cognitive deficits in hospitalized patients with chronic schizophrenia: a randomized controlled trial.舞蹈干预对住院慢性精神分裂症患者临床症状及认知缺陷的影响：一项随机对照试验。
PeerJ. 2025 Aug 21;13:e19840. doi: 10.7717/peerj.19840. eCollection 2025.
6
An open-access EEG dataset from indigenous African populations for schizophrenia research.一个来自非洲本土人群的用于精神分裂症研究的开放获取脑电图数据集。
Data Brief. 2025 Jul 28;62:111934. doi: 10.1016/j.dib.2025.111934. eCollection 2025 Oct.
7
Disturbances in Resting State Functional Connectivity in Schizophrenia: A Study of Hippocampal Subregions, the Parahippocampal Gyrus and Functional Brain Networks.精神分裂症静息态功能连接的紊乱：海马亚区、海马旁回及脑功能网络的研究
Diagnostics (Basel). 2025 Aug 4;15(15):1955. doi: 10.3390/diagnostics15151955.
8
The neuroreceptors and transporters underlying spontaneous brain activity.自发性脑活动背后的神经受体和转运体。
Commun Biol. 2025 Jul 30;8(1):1130. doi: 10.1038/s42003-025-08492-z.
9
The antipsychotics functional index (AFI) in schizophrenia.精神分裂症中的抗精神病药物功能指数（AFI）
Front Pharmacol. 2025 Jul 2;16:1591763. doi: 10.3389/fphar.2025.1591763. eCollection 2025.
10
16p11.2 duplication shows early male-biased impacts on reward learning, but NMDA receptor antagonism reduces optimal choice selection in both wildtypes and 16p11.2 duplication.16p11.2重复显示出对奖励学习的早期雄性偏向性影响，但NMDA受体拮抗作用会降低野生型和16p11.2重复个体的最优选择。
bioRxiv. 2025 Jun 29:2025.06.28.662127. doi: 10.1101/2025.06.28.662127.
本文引用的文献
1
Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies.长效注射抗精神病药与口服抗精神病药治疗精神分裂症的比较：镜像研究的系统评价和荟萃分析。
J Clin Psychiatry. 2013 Oct;74(10):957-65. doi: 10.4088/JCP.13r08440.
2
“Meta-guidelines” for the management of patients with schizophrenia.精神分裂症患者管理的“元指南”。
CNS Spectr. 2013 Jun;18(3):150-162. doi: 10.1017/S109285291300014X.
3
Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.长效注射用抗精神病药物与口服抗精神病药物预防精神分裂症复发的比较：一项随机试验的荟萃分析
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
4
Life expectancy and cardiovascular mortality in persons with schizophrenia.精神分裂症患者的预期寿命和心血管死亡率。
Curr Opin Psychiatry. 2012 Mar;25(2):83-8. doi: 10.1097/YCO.0b013e32835035ca.
5
Evidence-based psychotherapy for schizophrenia: 2011 update.精神分裂症的循证心理治疗：2011年更新版
J Nerv Ment Dis. 2011 Aug;199(8):520-6. doi: 10.1097/NMD.0b013e318225ee78.
6
Cardiovascular aspects of antipsychotics.抗精神病药物的心血管方面。
Curr Opin Psychiatry. 2010 Nov;23(6):574-81. doi: 10.1097/YCO.0b013e32833f46c9.
7
Management of schizophrenia with obesity, metabolic, and endocrinological disorders.肥胖、代谢和内分泌紊乱的精神分裂症管理。
Psychiatr Clin North Am. 2009 Dec;32(4):775-94. doi: 10.1016/j.psc.2009.08.003.
8
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.第二代抗精神病药物在儿童和青少年首次使用期间的心脏代谢风险。
JAMA. 2009 Oct 28;302(16):1765-73. doi: 10.1001/jama.2009.1549.
9
Schizophrenia.精神分裂症
Lancet. 2009 Aug 22;374(9690):635-45. doi: 10.1016/S0140-6736(09)60995-8.
10
Influence of antipsychotics on mortality in schizophrenia: systematic review.抗精神病药物对精神分裂症死亡率的影响：系统评价
Schizophr Res. 2009 Aug;113(1):1-11. doi: 10.1016/j.schres.2009.05.018. Epub 2009 Jun 12.
Zotero 插件